JPWO2022045336A1 - - Google Patents
Info
- Publication number
- JPWO2022045336A1 JPWO2022045336A1 JP2022545758A JP2022545758A JPWO2022045336A1 JP WO2022045336 A1 JPWO2022045336 A1 JP WO2022045336A1 JP 2022545758 A JP2022545758 A JP 2022545758A JP 2022545758 A JP2022545758 A JP 2022545758A JP WO2022045336 A1 JPWO2022045336 A1 JP WO2022045336A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020145967 | 2020-08-31 | ||
| PCT/JP2021/031722 WO2022045336A1 (ja) | 2020-08-31 | 2021-08-30 | パーキンソン病の運動合併症治療薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022045336A1 true JPWO2022045336A1 (https=) | 2022-03-03 |
| JPWO2022045336A5 JPWO2022045336A5 (https=) | 2024-09-04 |
Family
ID=80353469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022545758A Pending JPWO2022045336A1 (https=) | 2020-08-31 | 2021-08-30 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11628169B2 (https=) |
| EP (1) | EP4218764A4 (https=) |
| JP (1) | JPWO2022045336A1 (https=) |
| KR (1) | KR20230058615A (https=) |
| CN (1) | CN116113402A (https=) |
| AU (1) | AU2021332775A1 (https=) |
| CA (1) | CA3189670A1 (https=) |
| MX (1) | MX2023002422A (https=) |
| TW (1) | TW202227080A (https=) |
| WO (1) | WO2022045336A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116113402A (zh) * | 2020-08-31 | 2023-05-12 | 住友制药株式会社 | 帕金森病的运动并发症治疗药 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11228414A (ja) * | 1998-02-06 | 1999-08-24 | Sumitomo Pharmaceut Co Ltd | タンドスピロン経皮剤 |
| JPH11228454A (ja) * | 1998-02-17 | 1999-08-24 | Sumitomo Chem Co Ltd | アルキニル置換アリールブロミド類の製造方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4507303A (en) | 1981-12-22 | 1985-03-26 | Sumitomo Chemical Company, Limited | Succinimide derivatives, compositions and method of use |
| JPS58126865A (ja) | 1981-12-22 | 1983-07-28 | Sumitomo Chem Co Ltd | 環状イミド誘導体及びその酸付加塩 |
| US5633009A (en) * | 1990-11-28 | 1997-05-27 | Sano Corporation | Transdermal administration of azapirones |
| JP2002020291A (ja) | 2000-06-30 | 2002-01-23 | Sumitomo Pharmaceut Co Ltd | 認知機能障害の治療剤 |
| GB0027020D0 (en) * | 2000-11-03 | 2000-12-20 | Univ Manchester | Treatment of movement disorders |
| JPWO2005117886A1 (ja) | 2004-06-01 | 2008-04-03 | 久光製薬株式会社 | 貼付剤 |
| ATE413166T1 (de) | 2004-11-22 | 2008-11-15 | Hisamitsu Pharmaceutical Co | Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff |
| JP4873871B2 (ja) | 2005-02-28 | 2012-02-08 | 久光製薬株式会社 | 粘着剤及び貼付剤 |
| JP5243254B2 (ja) | 2006-10-11 | 2013-07-24 | 久光製薬株式会社 | 結晶含有貼付剤 |
| CA2839350A1 (en) | 2011-07-05 | 2013-01-10 | Contera Pharma Aps | The use of serotonin receptor agonists for treatment of movement disorders |
| CN104411301B (zh) | 2012-04-18 | 2018-02-06 | 康特拉医药公司 | 适于改善运动障碍治疗的口服药物配方 |
| KR20210107729A (ko) * | 2018-12-20 | 2021-09-01 | 콘테라 파르마 에이/에스 | 운동 장애의 치료 |
| JP2020145967A (ja) | 2019-03-13 | 2020-09-17 | 日清食品ホールディングス株式会社 | プライマー及び特定昆虫の検出方法 |
| US10758535B1 (en) | 2019-04-26 | 2020-09-01 | Sumitomo Dainippon Pharma Co., Ltd. | Therapeutic drug for dyskinesia |
| WO2021166987A1 (ja) | 2020-02-19 | 2021-08-26 | 大日本住友製薬株式会社 | 経皮吸収製剤 |
| CN116113402A (zh) * | 2020-08-31 | 2023-05-12 | 住友制药株式会社 | 帕金森病的运动并发症治疗药 |
-
2021
- 2021-08-30 CN CN202180053119.3A patent/CN116113402A/zh active Pending
- 2021-08-30 US US17/461,024 patent/US11628169B2/en active Active
- 2021-08-30 MX MX2023002422A patent/MX2023002422A/es unknown
- 2021-08-30 WO PCT/JP2021/031722 patent/WO2022045336A1/ja not_active Ceased
- 2021-08-30 KR KR1020237005487A patent/KR20230058615A/ko not_active Withdrawn
- 2021-08-30 CA CA3189670A patent/CA3189670A1/en active Pending
- 2021-08-30 JP JP2022545758A patent/JPWO2022045336A1/ja active Pending
- 2021-08-30 AU AU2021332775A patent/AU2021332775A1/en not_active Abandoned
- 2021-08-30 TW TW110132143A patent/TW202227080A/zh unknown
- 2021-08-30 EP EP21861757.9A patent/EP4218764A4/en active Pending
-
2023
- 2023-02-24 US US18/113,887 patent/US20230241062A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11228414A (ja) * | 1998-02-06 | 1999-08-24 | Sumitomo Pharmaceut Co Ltd | タンドスピロン経皮剤 |
| JPH11228454A (ja) * | 1998-02-17 | 1999-08-24 | Sumitomo Chem Co Ltd | アルキニル置換アリールブロミド類の製造方法 |
Non-Patent Citations (2)
| Title |
|---|
| ADVANCES IN NEUROREGULATION AND NEUROPROTECTION, JPN6025038079, 2005, pages 369 - 378, ISSN: 0005687829 * |
| 精神科治療学, vol. 14, no. 11, JPN6025038078, 1999, pages 1271 - 1274, ISSN: 0005787045 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116113402A (zh) | 2023-05-12 |
| WO2022045336A1 (ja) | 2022-03-03 |
| EP4218764A1 (en) | 2023-08-02 |
| US11628169B2 (en) | 2023-04-18 |
| KR20230058615A (ko) | 2023-05-03 |
| TW202227080A (zh) | 2022-07-16 |
| CA3189670A1 (en) | 2022-03-03 |
| EP4218764A4 (en) | 2024-10-02 |
| US20220062282A1 (en) | 2022-03-03 |
| AU2021332775A9 (en) | 2024-09-26 |
| MX2023002422A (es) | 2023-03-22 |
| US20230241062A1 (en) | 2023-08-03 |
| AU2021332775A1 (en) | 2023-04-27 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20230728 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20230904 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240827 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240827 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250916 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251023 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20260203 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260424 |